238 related articles for article (PubMed ID: 23845105)
1. Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
Liu S; Hsieh D; Yang YL; Xu Z; Peto C; Jablons DM; You L
BMC Pharmacol Toxicol; 2013 Jul; 14():36. PubMed ID: 23845105
[TBL] [Abstract][Full Text] [Related]
2. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
Hung MS; Xu Z; Lin YC; Mao JH; Yang CT; Chang PJ; Jablons DM; You L
BMC Cancer; 2009 May; 9():135. PubMed ID: 19419583
[TBL] [Abstract][Full Text] [Related]
3. TF--a novel cell-permeable and selective inhibitor of human protein kinase CK2 induces apoptosis in the prostate cancer cell line LNCaP.
Götz C; Gratz A; Kucklaender U; Jose J
Biochim Biophys Acta; 2012 Jul; 1820(7):970-7. PubMed ID: 22387500
[TBL] [Abstract][Full Text] [Related]
4. In Silico and In Vitro Studies of Natural Compounds as Human CK2 Inhibitors.
Haidar S; Jürgens F; Aichele D; Jose J
Curr Comput Aided Drug Des; 2021; 17(2):323-331. PubMed ID: 32160849
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and in Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2.
Haidar S; Aichele D; Birus R; Hielscher J; Laitinen T; Poso A; Jose J
Molecules; 2019 Apr; 24(7):. PubMed ID: 30965682
[TBL] [Abstract][Full Text] [Related]
6. Coumestrol Epigenetically Suppresses Cancer Cell Proliferation: Coumestrol Is a Natural Haspin Kinase Inhibitor.
Kim JE; Lee SY; Jang M; Choi HK; Kim JH; Chen H; Lim TG; Dong Z; Lee KW
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064398
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility.
Battistutta R; Lolli G
J Nat Prod; 2019 Apr; 82(4):1014-1018. PubMed ID: 30840451
[TBL] [Abstract][Full Text] [Related]
8. Structure-based identification of novel CK2 inhibitors with a linear 2-propenone scaffold as anti-cancer agents.
Qi X; Zhang N; Zhao L; Hu L; Cortopassi WA; Jacobson MP; Li X; Zhong R
Biochem Biophys Res Commun; 2019 Apr; 512(2):208-212. PubMed ID: 30878184
[TBL] [Abstract][Full Text] [Related]
9. Antitumoral activity of allosteric inhibitors of protein kinase CK2.
Moucadel V; Prudent R; Sautel CF; Teillet F; Barette C; Lafanechere L; Receveur-Brechot V; Cochet C
Oncotarget; 2011 Dec; 2(12):997-1010. PubMed ID: 22184283
[TBL] [Abstract][Full Text] [Related]
10. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
[TBL] [Abstract][Full Text] [Related]
11. Expanding the chemical diversity of CK2 inhibitors.
Prudent R; Moucadel V; López-Ramos M; Aci S; Laudet B; Mouawad L; Barette C; Einhorn J; Einhorn C; Denis JN; Bisson G; Schmidt F; Roy S; Lafanechere L; Florent JC; Cochet C
Mol Cell Biochem; 2008 Sep; 316(1-2):71-85. PubMed ID: 18563535
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth.
Zhu D; Hensel J; Hilgraf R; Abbasian M; Pornillos O; Deyanat-Yazdi G; Hua XH; Cox S
Mol Cell Biochem; 2010 Jan; 333(1-2):159-67. PubMed ID: 19629644
[TBL] [Abstract][Full Text] [Related]
13. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
Pucko E; Ostrowski R; Matyja E
Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
Quotti Tubi L; Gurrieri C; Brancalion A; Bonaldi L; Bertorelle R; Manni S; Pavan L; Lessi F; Zambello R; Trentin L; Adami F; Ruzzene M; Pinna LA; Semenzato G; Piazza F
J Hematol Oncol; 2013 Oct; 6():78. PubMed ID: 24283803
[TBL] [Abstract][Full Text] [Related]
15. Coumestrol induces senescence through protein kinase CKII inhibition-mediated reactive oxygen species production in human breast cancer and colon cancer cells.
Lee YH; Yuk HJ; Park KH; Bae YS
Food Chem; 2013 Nov; 141(1):381-8. PubMed ID: 23768371
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
[TBL] [Abstract][Full Text] [Related]
17. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.
Guerra B; Hochscherf J; Jensen NB; Issinger OG
Mol Cell Biochem; 2015 Aug; 406(1-2):151-61. PubMed ID: 25963666
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors.
Oramas-Royo S; Haidar S; Amesty Á; Martín-Acosta P; Feresin G; Tapia A; Aichele D; Jose J; Estévez-Braun A
Bioorg Chem; 2020 Jan; 95():103520. PubMed ID: 31887475
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 4,5,6,7-tetrahalogeno-1H-isoindole-1,3(2H)-diones as inhibitors of human protein kinase CK2.
Golub AG; Yakovenko OY; Prykhod'ko AO; Lukashov SS; Bdzhola VG; Yarmoluk SM
Biochim Biophys Acta; 2008 Jan; 1784(1):143-9. PubMed ID: 18021749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
